Cis-Platinum, Doxorubicin, and Methotrexate Treatment for Recurrent Cervical Cancer
Cis-Platinum, Doxorubicin, and Methotrexate Treatment for Recurrent Cervical Cancer
复制标题
顺铂、阿霉素和甲氨蝶呤治疗复发性宫颈癌
作者：
J. Wheelock;H. Krebs;D. Goplerud;M. Myers
A combination of cis-platinum, doxorubicin (Adriamycin), and methotrexate was used to treat 28 patients with recurrent cervical cancer. Seven patients achieved a partial response with a median duration of ten months. Two patients achieved a complete response with a median duration of 14 months. The overall response rate was 32%. Ten patients with stable disease had a median progression-free interval of 4.5 months. Toxicity was acceptable.
